drugset / Trial / NCT01744314

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma

NCT01744314

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients who present to our institution with a traumatic injury to their elbow who need operative management will be randomized to one of two groups; a treatment arm and a control arm. The treatment arm will receive a three-week postoperative course of indomethacin while the control group will not. We will follow both groups to assess whether or not indomethacin prophylaxis affects the rate of heterotopic ossification.

Timeline

Start
2012-11
Primary completion
2019-11
Completion
2019-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 25 mg
Background Pantoprazole Other / unclassified 40 mg

Indications

No indication recorded.